MRP ₹219
₹175.2
₹21.9/Units
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionJalra-OD 100 mg Tablet is a DPP-4 inhibitor used to manage type 2 diabetes by improving the body’s insulin response and regulating glucose production. It can be used as a standalone treatment of diabetes or in combination with other medications like metformin for enhanced efficacy.
Consult your doctor for the correct dosage based on your condition. Inform your physician of any pre-existing health issues, report side effects promptly, and continue taking the medicine as prescribed.
Jalra-OD 100 mg Tablet is used to treat type 2 diabetes mellitus. It contains vildagliptin, which helps control blood sugar by increasing insulin release and decreasing glucose production in the liver, supporting better blood sugar regulation.
Taking Jalra-OD 100 mg Tablet is straightforward. Here are the steps:
Swallow the tablet whole with a glass of water.
Avoid crushing or chewing the tablet.
The medicine can be taken with or without food, as per your convenience.
Do not alter the dosage without consulting your doctor.
If you have any further questions about how to take this medicine, consult your doctor.
Jalra-OD 100 mg Tablet is taken orally.
Jalra-OD 100 mg Tablet may cause side effects such as nausea, diarrhea, headache, dizziness, and hypoglycemia (low blood sugar levels). Symptoms of hypoglycemia may include shaking, sweating, hunger, and dizziness. If these symptoms persist or worsen, consult your doctor.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Jalra-OD 100 mg Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Nausea: Try taking Jalra-OD 100 mg Tablet with food to lessen this effect.
Hypoglycaemia: If low blood sugar occurs after taking this medicine, consider having a small snack or drink containing sugar.
Jalra-OD 100 mg Tablet contains vildagliptin (100 mg), which has the following effects on the body:
DPP-4 Inhibition: Vildagliptin works by inhibiting an enzyme called dipeptidyl peptidase-4 (DPP-4). This enzyme is involved in the breakdown of hormones called incretins which regulate blood sugar levels.
Increased Insulin Secretion: By inhibiting DPP-4, vildagliptin increases the levels of incretin hormones. These hormones stimulate your pancreas to produce more insulin when blood glucose levels are high.
Reduced Glucagon Levels: Vildagliptin also helps reduce glucagon secretion from the liver. Glucagon is a hormone that raises blood sugar levels; reducing its secretion helps lower blood sugar.
Risk Minimisation: The actions of vildagliptin are dependent only on the presence of high glucose levels, which minimises the risk of hypoglycaemia or low blood sugar.
Caution is advised while taking Jalra-OD 100 mg Tablet during pregnancy. It's best to consult your doctor before taking this medicine if you're expecting.
If you're nursing, it's advisable to discuss with your doctor before using this medicine.
Consuming alcohol while taking vildagliptin can increase the risk of low blood sugar (hypoglycaemia) and affect liver function. It is advisable to limit alcohol intake and monitor blood sugar levels closely.
If you've a history of liver diseases, be cautious while taking Jalra-OD 100 mg Tablet as it may affect liver function. Your doctor can provide guidance based on your health status.
Patients with a history of kidney problems should take Jalra-OD 100 mg Tablet with care. Discuss your medical history with your doctor before starting this medicine.
Jalra-OD 100 mg Tablet might cause dizziness in some patients. Be careful while driving or operating heavy machinery until you know how the medicine affects you.
Jalra-OD 100 mg Tablet is contraindicated for people allergic to vildagliptin or any of its ingredients. If you've had an allergic reaction to similar medicines in the past, talk to your doctor before starting this medication.
Jalra-OD 100 mg Tablet isn't recommended for children below 18 years of age. Always consult your doctor about suitable alternatives if necessary.
Older patients should take Jalra-OD 100 mg Tablet under medical supervision as they may be more susceptible to its side effects and may have liver or kidney issues. Your doctor will guide you based on your health status.
Jalra-OD 100 mg Tablet interacts with the following medicines:
CYP3A4 Inducers: Medications such as rifampicin can reduce the effectiveness of Jalra-OD 100 mg Tablet by inducing CYP3A4, an enzyme that plays a role in its metabolism.
Insulin and Sulfonylureas: Medicines like insulin and glimepiride may increase the risk of low blood sugar (hypoglycaemia) when taken with Jalra-OD 100 mg Tablet.
ACE inhibitors: Medicines like lisinopril or enalapril could increase the risk of swelling beneath the skin (angioedema) when taken together with Jalra-OD 100 mg Tablet.
Jalra-OD 100 mg Tablet does not have any known specific food interactions.
Jalra-OD 100 mg Tablet interacts with the following diseases:
Pancreatitis: If you have had pancreatitis in the past, taking Jalra-OD 100 mg Tablet could potentially exacerbate this condition.
Heart Failure: If you have a history of heart failure, using Jalra-OD 100 mg Tablet could potentially worsen your condition.
Diabetic Ketoacidosis: Patients with diabetic ketoacidosis, a severe complication of diabetes, should avoid using Jalra-OD 100 mg Tablet.
The Jalra-OD 100 mg Tablet should be taken as suggested by your doctor. The dosage might vary based on certain individual factors like the severity of your condition and how your body responds to the medicine. Always stick to the prescribed dosage and never increase it without consulting your doctor.
Overdosing on Jalra-OD 100 mg Tablet could cause symptoms similar to its side effects such as nausea, headache, or dizziness. It's important not to panic but to inform your doctor if you suspect an overdose.
If you forget to take your dose of Jalra-OD 100 mg Tablet, take it as soon as you remember. But if it's almost time for your next dose, skip the missed one and continue with your routine schedule. Never take extra doses without consulting with your doctor.
Store Jalra-OD 100 mg Tablet at room temperature, ideally below 30°C.
Keep the medicine in a dry place, safe from moisture and direct sunlight.
Always retain the tablets in their original packaging until you need to take them.
Ensure you keep the medicine out of reach of children.
Use your Jalra-OD 100 mg Tablet before the expiry date printed on the label.
Make sure to maintain a balanced diet low in sugar and high in fibre, as this can help manage your type 2 diabetes alongside taking Jalra-OD 100 mg Tablet.
Regular physical activity is key for managing type 2 diabetes. Try to incorporate at least 30 minutes of moderate-intensity exercise into your daily routine. This could include brisk walking, swimming or cycling.
| Dosage Forms Available | Tablet |
| Habit Forming | No |
| Ailment | Type 2 Diabetes Mellitus |
| Drug Category | DPP-4 Inhibitor |
| Therapeutic Category | Antidiabetic |
This medicine is used to manage type 2 diabetes mellitus in adults, along with diet and exercise.
It contains vildagliptin that inhibits an enzyme, increasing insulin production and reducing glucagon levels, thereby lowering blood sugar.
The tablet is taken orally, once daily, with or without food. It should be swallowed whole and not chewed or crushed.
Common side effects can include nausea, diarrhoea, headache, dizziness and upper respiratory tract infection.
It should be used carefully by individuals with a history of pancreatitis, gallstones, heart failure or liver disease.
Certain medicines can interact with vildagliptin. Always consult your doctor before starting any new medication.
Store it at room temperature (below 30°C), in a dry place protected from sunlight. Keep it out of reach of children.
Check out Editorial Policy
NVR & FB. (2020). Galvus. In Galvus (pp. 1–19). https://www.novartis.com/sg-en/sites/novartis_sg/files/Galvus-Jul2020.SIN-App051120.pdf
Vildagliptin: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB04876
Mathieu, C., Kozlovski, P., Paldánius, P. M., Foley, J. E., Modgill, V., Evans, M., & Serban, C. (2017). Clinical Safety and Tolerability of Vildagliptin – Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance. European Endocrinology, 13(02), 68. https://doi.org/10.17925/ee.2017.13.02.68
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
64% CHEAPER
6307 users bought this instead
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.21.0
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
